Kythera Biopharmaceuticals Inc (KYTH) Return on Equity ROE from the second quarter 2015 to second quarter 2014 and annually, average high and low, overall ranking from Jun 30 2015 to Jun 30 2014 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Kythera Biopharmaceuticals Inc  (KYTH)

Kythera Biopharmaceuticals Inc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Kythera Biopharmaceuticals Inc in the second quarter 2015?
Kythera Biopharmaceuticals Inc recorded a cumulative net loss of $-113 million during 12 months ending in the second quarter 2015, resulting in a negative return on equity (ROE) of -98.64%.

Within the Major Pharmaceutical Preparations industry 203 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2015 from 0 to 4380.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2015)
II. Quarter		 (Mar 31 2015)
I. Quarter		 (Dec 31 2014)
IV. Quarter		 (Sep 30 2014)
III. Quarter		 (Jun 30 2014)
II. Quarter
Y / Y Equity Change 47.24 % 47.36 % -60.33 % 116.84 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -113 -95 -136 -125 -114
Return On Equity (TTM) -98.64 % -92.7 % -152.81 % -112.63 % -113.84 %
KYTH's Total Ranking # 4380 # 0 # 0 # 0 # 0
Equity (TTM) in Millions 146 171 59 80 99
Seq. Equity Change -14.17 % 187.14 % -25.94 % -19.34 % -14.1 %
Seq. Net Income Change - - - - -

Back to KYTH Management Effectiveness >> KYTH's 5 Years Annual ROE >> Compare KYTH ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 204
Sector # 438
Overall # 4380

Return On Equity Statistics
High Average Low
-71.97 %
-136.5 %
-350.5 %
(Dec 31 2013)   (Jun 30 2013)





KYTH Annual Return On Equity (Dec 31 2014)
2014		 (Dec 31 2013)
2013		 (Dec 31 2012)
2012

Total Equity in Millions 59 150 69 0 0
Y / Y Equity Change -60.33 % 117.45 % - - -
Net Income in Millions -136 -52 -37 0 0
Y / Y Net Income Change - - - - -
Return On Equity -228.17 % -34.64 % -53.4 % - -

Back to KYTH Management Effectiveness >> KYTH's 5 Years Annual ROE >> Compare KYTH ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
KYTH's' Return on Equity at Yahoo Finance
KYTH's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for KYTH's Competitors
Subscribers only: Roe for Kythera Biopharmaceuticals Inc's Suppliers
Subscribers only: Return On Equity for KYTH's Customers




Companies with similar Return On Equity at Jun 30 2015, within Healthcare Sector ROE

Date modified: 2026-09-26T07:14:03+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.